Hematogenix
Hassina Merdjemak has extensive experience in the field of flow cytometry, currently serving as a Flowcytometry Lab Scientist at Hematogenix since April 2011. In this role, Merdjemak analyzes blood, bone marrow, and tissue using the Navios flow cytometer, specializing in the diagnosis of acute and chronic leukemia, lymphomas, paroxysmal nocturnal hemoglobinuria, and multiple myeloma. Prior to this position, Merdjemak held roles as Supervisor and Team Lead in flow cytometry at Cochin Hospital from September 1992 to July 1996 and completed a Doctor Residency during that time. Merdjemak earned a Medical Doctor degree from Centre Hospitalier Universitaire de Constantine between 1986 and 1992 and a University Diploma in Endocrinology and Metabolism from Ecole de Medecine Rene Descartes from 1991 to 1996.
This person is not in the org chart
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant